Fundraising Fox

Steve Tregay

Investor

Managing Partner at Mission Biocapital

Cambridge, Massachusetts

Writes $500K checks · typically $1.5M

FoundedAlessa Therapeutics

About

Steve Tregay, a big‑pharma executive, venture capitalist and biotech founder‑CEO, serves as founding CEO and guides companies from research to clinical development while chairing LabCentral, building shared labs in Cambridge.

Invests in

AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials

Experience

  1. Mission BioCapitalManaging General Partnercurrent2019 — presentCambridge, MA
  2. FORMA TherapeuticsFounder, President and CEO2008 — 2019
  3. Compass Therapeutics LLCFounder and Chairman of the Board of Directors2015 — 2019Cambridge MA
  4. Novartis Venture FundManaging Director2006 — 2009
  5. Novartis Institutes for BioMedical Research (NIBR)Executive Director2004 — 2006
  6. Array BioPharmaBusiness Development2001 — 2004

Education

  1. Harvard UniversityPh.D., MS1993 — 1999
  2. Davidson CollegeBS, Chemistry1989 — 1993

Skills & more

Drug Discovery99Biotechnology99Pharmaceutical Industry99Drug Design21Drug Development94Medicinal Chemistry23Oncology99Lifesciences37Technology Transfer47Clinical Development41CRO14Cancer9
+12 moreChemistryOrganic ChemistryBiopharmaceuticalsCommercializationNeuroscienceGLPBiomarkersVenture CapitalClinical TrialsBiochemistryPharmacologyGMP

From Steve's professional profile.

Same school

Shared employers

Deals · 1

Compass Therapeutics LLCBoard seat

via Mission Biocapital · filed Jul 2018 · $170.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Mission Biocapital